In cancer patients, choosing fertility preservation is really effective in allowing these women to achieve the goal of having a child after breast cancer.
This is confirmed by an important new study published in ‘Jama Oncology’ by the prestigious Karolinska Institute in Stockholm.
Research has in fact confirmed that breast cancer patients who resort to egg freezing before the drug treatments necessary to treat their disease, have a better chance of achieving success with medically assisted procreation, thus giving birth to a baby, without any additional mortality risk.
The results of the Swedish study conducted on 425 cancer patients undergoing fertility preservation treatments in Sweden between 1994 and 2017, and 850 women still with breast cancer, but who did not freeze their eggs, show that although a pregnancy with positive outcome is possible in both cases, opting for the preservation of fertility is associated with a rate of children born more than 2 times higher, with no negative effect on survival, in an average follow-up of 5.2 years.
In total, in the fertility preservation study group, 97 women (22.8%) had at least one child after breast cancer, compared with 74 women (8.7%) in the cohort who has not received treatment. Furthermore, women in the group that froze eggs were more likely to have more than one child after cancer (37.3%) than their counterpart (17.7%).
All the clinics of GeneraLife have a high level of expertise in fertility preservation programs, whatever your case is.
